Perthera advances clinical decision support for oncologists and their patients combining multiomic molecular profiling with patient clinical history in its patented Precision Oncology Platform. The resulting Perthera Report, with precisely ranked therapies, identifies the best treatment options for the individual patient.
Recommendations in the Perthera Report, used by 1500+ oncologists and 400+ hospitals and validated in peer-reviewed, high impact journals, show a 2.4X improvement in PFS. Clients and partners include LabCorp, Mayo Clinic, AstraZeneca and the Cancer Moonshot Program.